The old approach to forest replanting was basically educated guesswork. You’d choose species that historically did well in an area, plant them, and hope for the best. But with diseases like myrtle rust and phytophthora wiping out entire stands, that strategy doesn’t cut it anymore.

Genetic testing is changing how we select trees for replanting programs. Instead of waiting years to see which seedlings survive disease pressure, foresters can now screen for resistance markers at the DNA level before anything goes in the ground.

How Genetic Screening Works

The process starts with collecting samples from trees that survived disease outbreaks. If a stand of spotted gum got hammered by a fungal pathogen but 5% of trees remained healthy, those survivors likely carry resistance genes worth studying.

Researchers extract DNA from needle or leaf tissue, then use sequencing technology to identify genetic markers associated with disease resistance. These markers act like flags in the genome, indicating which trees inherited the right defensive traits.

Once you’ve identified the markers, you can screen thousands of seedlings quickly. A small tissue sample from each seedling gets processed through a lab, and within days you know which ones carry resistance genes. The seedlings without those markers? They don’t make it to the replanting program.

Real-World Applications

Australia’s eucalypt breeding programs are using this approach extensively. Myrtle rust has been devastating for certain species, but genetic testing has helped identify resistant populations that can form the basis for new plantings.

The technology isn’t perfect yet. Some diseases are controlled by multiple genes working together, which makes screening more complex. And lab testing adds cost to seedling production. But for high-value restoration projects or commercial plantations in disease-prone areas, the investment makes sense.

Organizations managing large-scale data analysis for these breeding programs often work with specialists who can handle complex genetic datasets. The Team400 team has worked on similar pattern-recognition challenges in agricultural sectors, though the forestry applications require specific domain expertise.

Beyond Single-Disease Resistance

What’s really interesting is that some genetic markers correlate with resistance to multiple pathogens. A tree that shows strong resistance to one type of root rot might also handle other fungal diseases better than average.

This broad-spectrum resistance is valuable because it’s impossible to predict every disease threat a tree will face over its 50-year lifespan. Climate change is shifting disease distributions, and new pathogens keep arriving. Trees with robust immune systems have better odds of handling whatever comes.

Genetic diversity still matters, though. You don’t want to plant a monoculture of genetically identical disease-resistant trees. If they all share the same resistance genes and a pathogen evolves to overcome that specific defense, you’re back to square one.

Practical Constraints

The biggest limitation right now is cost. Genetic testing isn’t cheap, especially for native species that haven’t been extensively studied. Eucalypts and pines get the most research attention because of their commercial value, but many native species lack the genomic resources needed for marker-assisted selection.

There’s also the question of what happens to genetic diversity in wild populations. If everyone starts planting seedlings from the same disease-resistant parent trees, you narrow the gene pool. That might solve today’s disease problem but create vulnerabilities down the track.

Looking Forward

As sequencing costs drop and genomic databases expand, genetic testing will become standard practice for more species. The technology that was cutting-edge five years ago is now routine for major breeding programs.

Field trials still matter. Genetic markers indicate potential, but actual performance in different soil types, climates, and disease pressures needs verification. The best programs combine genetic screening with traditional provenance trials, using DNA data to shortlist candidates and field testing to confirm results.

For regions facing serious disease threats, genetic testing offers a practical path forward. It’s not about creating super-trees, just identifying the individuals that nature already equipped with better defenses and making sure those genetics get into the next generation of forests.